Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Ivabradine Hydrochloride Intermediates With High Purity Ivabradine Hydrochloride CAS 148849-67-6 4,5-Dimethoxy-1-Cyanobenzocyclobutane CAS 35202-54-1 (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride CAS 866783-13-3 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one CAS 73942-87-7 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one CAS 148870-57-9 3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one CAS 85175-59-3| Item | Specifications |
| Appearance | Off-White or White Powder |
| Identification | HPLC, NMR; LC-MS |
| Purity / Analysis Method | >99.0% (HPLC) |
| Loss on Drying | <0.50% (Dry it at 60℃ in vacuum till a constant weight) |
| Residue on Ignition | <0.10% |
| Related Substances | |
| Individual Impurity | <0.50% |
| Total Impurities | <1.00% |
| Heavy Metals | <10ppm |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Ivabradine Hydrochloride (CAS: 148849-67-6) |
Description:
Specifications:
Package & Storage:
| Chemical Name | 3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one |
| Synonyms | Ivabradine Hydrochloride Side Chain; (Z)-3-(3-Chloropropyl)-7,8-diethyl-1H-benzo[d] azepin-2 (3H)-one; 7,8-Dimethoxy-3-(3-chloropropyl)-1,3-dihydro-2H-3-benzazepin-2-one |
| CAS Number | 85175-59-3 |
| CAT Number | RF-PI1807 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C15H18ClNO3 |
| Molecular Weight | 295.76 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one (CAS: 85175-59-3) is the side chain of Ivabradine Hydrochloride (CAS: 148849-67-6). Ivabradine and its medicinal salts, especially its hydrochloride, have very important pharmacological and therapeutic properties, especially, in slowing down the heart rate. Relating compounds can be used to treat or prevent various clinical myocardial ischemia conditions, such as angina pectoris, myocardial infarction and related rhythm disorders, various pathologies involving rhythm disorders, especially supraventricular rhythm disorders.
